...
首页> 外文期刊>Washington Drug Letter >Postmarket Reporting Detailed In Draft Combo Product Rule
【24h】

Postmarket Reporting Detailed In Draft Combo Product Rule

机译:组合产品规则草案中详细介绍了上市后报告

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Sponsors of combination products should follow the postmarket reporting requirements of the type of application used to get the FDA's approval or clearance, as well as provide additional reports for the product's constituent parts, under a proposed rule issued by the FDA.rnThe additional reports would be necessary only if the original approval or clearance did not require them or if they were required by rules for the constituent part at times earlier than those mandated by the original approval or clearance.
机译:组合产品的保荐人应遵循获得FDA批准或批准的申请类型的上市后报告要求,并根据FDA发布的拟议规则提供产品组成部分的其他报告。仅当原始批准或许可中没有要求时,或者在组成部分的规则中早于原始批准或许可所要求的时间时才需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号